Furthermore, endothelial dysfunction exacerbates atherogenesis through the dysregulation of vasoactive substances, characterized by diminished NO bioavailability and altered endothelin-1 (ET-1) secretion, coupled with enhanced platelet activation and prothrombotic tendency. Here, EDN1 is linked to endothelial dysfunction.